Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Should You Sell?
by Mitch Edgeman · The Markets DailyMerck KGaA (OTCMKTS:MKGAF – Get Free Report) shares gapped down prior to trading on Friday . The stock had previously closed at $142.41, but opened at $137.1110. Merck KGaA shares last traded at $141.9190, with a volume of 114 shares changing hands.
Merck KGaA Trading Down 5.1%
The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average of $135.58 and a two-hundred day moving average of $132.22. The firm has a market capitalization of $17.47 billion, a P/E ratio of 20.64 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
- Five stocks we like better than Merck KGaA
- How Can Investors Benefit From After-Hours Trading
- Chewy Stock Just Flashed a Major Buy Signal for 2026
- 3 REITs to Buy and Hold for the Long Term
- Broadcom Slips Post-Earnings Even as AI Demand Goes Parabolic
- What Does Downgrade Mean in Investing?
- Qualcomm Just Got Called an AI Loser—So Why Is It Rallying?